OCUL
NASDAQ · Pharmaceuticals
Ocular Therapeutix Inc
$9.43
+0.06 (+0.64%)
Analyst Consensus
Strong Buy
18
Analysts
High
Coverage
Price Target
Analyst Price Target
+501.3% upside
Low Target
$44.23
Average Target
$56.70
High Target
$95.28
Current Price
$9.43
Current
$9.43
$9.43
Target
$56.70
$56.70
$44.23
$56.70 avg
$95.28
Scenario Analysis
Bear Case
$44.23
369.0%
Low target
Base Case
$56.70
+501.3%
Avg target
Bull Case
$95.28
+910.4%
High target
Risk/Reward
2.5x
Favorable
Price in Context
52-Week High
$16.44
-42.6% from high
52-Week Low
$6.23
+51.4% from low
Target vs 52W High
$56.70
+244.9% vs high
Next Earnings Report
May 11, 2026 · After Market Close
Today
EPS Est: $-0.32
Earnings in today. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals